| Smiles |
S1(C3(=NC(=C1)C(=O)NC(C=2(SC=C(N=2)C(=O)NC(C=8(SC=C(C5(=C(C4(=NC(C(NC(C(NC3=CC)=O)C(O)C)=O)=CS4))C=CC(=N5)C=6(SC=C(N=6)C=7(SC=C(N=7)C(=O)NC(C(=O)NCC(O)C)=CC))))N=8))C(O)C))C(O)(C)C))
|
| CAS number |
59979-01-0
|
| Polar Surface Area |
515,19
|
| calculated LogS |
-3,999
|
| Molweight |
1160,39
|
| calculated LogP |
1,7202
|
| H-Acceptors |
23
|
| H-Donors |
10
|
| Ro5 violations |
3
|
| Druglikeness |
3,2373
|
| DrugScore |
0,3336692
|
| Mutagenic |
none
|
| Tumorigenic |
low
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,3725
|
| Rat Acute Toxicity |
2,5649
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
0,5559
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Non-inhibitor
|
| P-glycoprotein Inhibitor2 |
Non-inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,4852
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA+
|
| Structure |
59979-01-0
|
